Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Shock (Augusta, Ga.)|July 4, 2026
Temporal changes of the von Willebrand factor-ADAMTS13 axis during the first 24 hours in major trauma patients with isolated brain injury and without brain injury: a prospective observational studyPhilip Verdonck, Eva Janssens, Kirsten Van Laer, et al.
Molecular Oncology|December 24, 2025
Crucial parameters for precise copy number variation detection in formalin-fixed paraffin-embedded solid cancer samplesHanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, et al.
British Journal of Cancer|February 9, 2021
The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemicMarika Rasschaert, Pieterjan Vanclooster, Tim Mertens, et al.
Annals of Intensive Care|May 17, 2021
Fluid-induced harm in the hospital: look beyond volume and start considering sodium. From physiology towards recommendations for daily practice in hospitalized adultsNiels Van Regenmortel, Lynn Moers, Thomas Langer, et al.
Mediators of Inflammation|November 30, 2019
Pterygium Pathology: A Prospective Case-Control Study on Tear Film Cytokine LevelsSara I Van Acker, Michel Haagdorens, Ella Roelant, et al.
Pain Research & Management|August 12, 2025
Multidisciplinary Approach to Spinal Cord Stimulation for Persistent Spinal Pain Syndromes: A 65-Month Integrated Data Collection From the Belgian Neuro-Pain® Real-World Data RegisterLisa Bernaerts, Ella Roelant, Maarten Moens, et al.
Plos One|July 15, 2024
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC studyJolien Van den Bossche, Maxime De Laere, Koen Deschepper, et al.
BMJ Open|June 3, 2023
Randomised, controlled, open-label pragmatic trial evaluating changes in functional exercise capacity after primary careTess Volckaerts, Dirk Vissers, Chris Burtin, et al.
Frontiers in Immunology|April 29, 2024
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trialAnna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
BMJ Open|July 4, 2025
Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocolSiddharth Chhajlani, Jelka Kuiper, Philippe Beutels, et al.
Pageof 7